CompletedNCT00611806
Folate and vitamin B12 or placebo for negative symptoms in schizophrenia
About this title
Read the official source — NCT00611806Placebo comparisonAges 18–68United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 68 years. Other eligibility criteria applied.
- Listed locations
- Boston and 2 more locationsSee all locations and recruitment
Study information
Study start dateDecember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 140
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Dietary supplement, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 68 Years
- Official registry ID
- NCT00611806
- Official title
Show the full official title
A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston · Grand Rapids · Rochester
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 68 years. Other eligibility criteria applied.
